Septerna, INC. (SEPN) — 10-Q Filings
All 10-Q filings from Septerna, INC.. Browse 4 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (4)
-
Septerna Swings to Profit on Revenue Surge, Asset Sale
— Nov 10, 2025 Risk: medium
Septerna, Inc. reported a significant financial turnaround for the three months ended September 30, 2025, achieving a net income of $8.173 million, a substantia -
Septerna's Q2 Loss Widens to $35.6M Amid R&D Ramp-Up
— Aug 11, 2025 Risk: high
Septerna, Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with the prior year periods, as the company remains in the clini -
Septerna, Inc. Files Q1 2025 10-Q
— May 15, 2025 Risk: medium
Septerna, Inc. filed its 10-Q for the period ending March 31, 2025. The company's fiscal year ends on December 31st. Key dates include the IPO on October 28, 20 -
Septerna, Inc. Files Q3 2024 10-Q
— Nov 20, 2024 Risk: medium
Septerna, Inc. filed its 10-Q for the period ending September 30, 2024. The company, focused on pharmaceutical preparations, reported financial data for Q3 2024
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX